4Von Seidlein L,Kim DR,Ali M,et al.A multicentre study of shigella diarrhoea in six asian countries:disease burden,clinical manifestations,and microbiology.Plos Med,2006,3(9):353.
5Gao Q,Zheng HB, Luo D, et al. Facile synthesis of magnetic one- dimensional polyaniline and its application in magnetic solid phase extraction for fluoroquinolones in honey samples [ J ]. Anal Chim Acta,2012 ,720 :57-62.
6Hof H, Fahr A, Holfelder M, et al. Severe pneumococcal infections in the elderly-preventable by vaccination [ J ]. Z Gerontol Geriatr, 2013,46 (2) : 160-166.
7Abbasi S, Imtiaz A, Usman J, et al. Evaluation of the current trend of nalidixic acid susceptibility in typhaidal Salmonellae; a marker of therapeutic failure for the fluoroquinolones[ J]. Iran J Miembiol, 2011,3(2) :80-83.
8Castanheira M,I)eshpande LM, Jones RN, et al. Evaluation of quino- lone resistance-determining region mutations and effiux pump expres- sion in Neisseria meningitidis resistant to fluoroquinolones [ J ]. Diagn Microbiol Infect Dis,2012,72 ( 3 ) : 263-266.
9Rice LB. Mechanisms of Resistance and Clinical Relevance of Resistance to [3-Lactams, Glycopeptides, and Fluoroquinolones [ J]. Mayo Clin Proc,2012,87 (2) : 198-208.
10Kim H, Nakajima C, Kim YU, t al. Influence of lineage-speclfic amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones[ J]. Jpn J Infect Dis ,2012,65 ( 1 ) :72-74.
